HOME >> BIOLOGY >> NEWS
Jefferson scientists propose mechanism to control the body's red blood cell and platelet production

The new work may provide essential background for new therapeutic strategies in red blood cell and platelet disorders

Researchers at Jefferson Medical College have uncovered a potential switch that helps control the manufacture of red blood cells and blood-clotting platelets. By better understanding how the body keeps tight reins on this process, the scientists hope to someday therapeutically control blood cell production.

For our tissues to have the oxygen they crave, we need to have enough circulating red blood cells. Athletes, for example, may artificially increase the number of blood cells using a hormone, erythropoietin, which helps immature red blood cells mature. But at the same time, too many cells can cause sluggish circulation and stroke.

Controlling the amount of the hormone is one way of regulating red blood cell production. But there's another way, called "negative regulation," which involves blocking the growth and differentiation of red cell precursors. By activating the cell's own programmed suicide process, called apoptosis, researchers can halt the excessive production of red blood cells.

Cesare Peschle, M.D., professor of microbiology and immunology at Thomas Jefferson University in Philadelphia, Ruggero De Maria, M.D., and their co-workers at Jefferson's Kimmel Cancer Center and the Istituto Superiore di Sanita in Rome, found evidence that by activating so-called "death receptors" on the surface of immature red blood cells, an important protein called GATA-1 can be turned off. GATA-1 is crucial to the development of immature blood cells.

They report their work September 30 in the journal Nature. A News and Views article accompanies the research publication.

The scientists found that turning on immature red blood cell death receptors triggers caspases, a family of 14 cysteine enzymes that degrade critical cellular proteins, such as GATA-1. This culminates in
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
1-Oct-1999


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2019)... ... 06, 2019 , ... NDA Partners Chairman Carl Peck, ... with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert in ... joined the firm as an Expert Consultant. , Dr. Stanski has served in ...
(Date:11/6/2019)... ... November 06, 2019 , ... Genomenon® announced ... now includes the ability to search the entirety of the genomic literature by ... and rare diseases. , Patients, particularly those with rare diseases, don’t always have ...
(Date:11/5/2019)... Seattle, WA (PRWEB) , ... November 05, 2019 ... ... LeCuyer & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, ... Receiving her Doctor of Dental Surgery degree from the University of Washington, Dr. ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... 2019 , ... Supercomputing Conference – Cirrascale Cloud Services® ... Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, today announced ... software stack as part of its bare-metal cloud service offerings. In addition to ...
(Date:11/12/2019)... ... 12, 2019 , ... Peggy Lillis Foundation (PLF) has launched ... infection C. diff. The campaign, “See C. diff,” combines basic facts ... 30,000 people in the U.S. each year. The campaign also features a portrait ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By ... the Fusion Bx 2.0 will give urologists across Europe the ability to perform ...
(Date:10/30/2019)... ... October 30, 2019 , ... While using cold plasma to kill cancer cells ... Dakota School of Mines & Technology are exploring new ways to regulate cold ... , If successful, the technique would prove to be a drug-free, minimally invasive cancer ...
Breaking Biology Technology:
Cached News: